Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 2510-2510 ◽  
Author(s):  
Ursula Matulonis ◽  
Gerburg M. Wulf ◽  
Michael J. Birrer ◽  
Shannon Neville Westin ◽  
Philippa Quy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

2016 ◽  
Vol 22 (12) ◽  
pp. 2855-2864 ◽  
Author(s):  
Eve T. Rodler ◽  
Brenda F. Kurland ◽  
Melissa Griffin ◽  
Julie R. Gralow ◽  
Peggy Porter ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Brca Mutation

A phase I study of JS001, a humanized PD-1mAbin patients with advanced triple negative breast cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e15093-e15093 ◽  
Author(s):  
Li Bian ◽  
Huiqiang Zhang ◽  
Tao Wang ◽  
Shaohua Zhang ◽  
Jianbin Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document